For a broader overview of peptides studied in dermatology, see our guide to best peptides for skin research
Li X, Robinson SM, Gupta A, Saha K, Jiang Z, Moyano DF, et al
They are primarily prescribed for managing chronic metabolic conditions like Type 2 diabetes and clinical obesity
Oral semaglutide in a weight-loss dose, the tablet version of Wegovy, was approved at the end of 2025
Cardiovascular and Vascular Benefits: GLP-1s can reduce the risk of major cardiovascular events, such as nonfatal heart attacks, nonfatal strokes, and cardiovascular deatheven in patients without diabetes
Elle est galement utilise dans la prvention ou le traitement de diverses affections, notamment : La maladie dAlzheimer, Les maladies cardiovasculaires, Le diabte, Les problmes de fertilit (infertilit), Lobsit (4, 5)